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THERE is still much suffering from urinary tract infection (UTI). Consultation
rates vary between 12-60 per thousand 1-3 and, as shown in Table 1, it is also a
common cause of absenteeism from work. Prophylaxis is therefore indicated both
on medical and economic grounds. It is less clear whether effective prophylaxis
would have an impact on the mortality associated with UTI since long-term
follow-up studies of patients with UTI have shown how rarely these infections
progress to impairment of kidney function in the absence of obstruction. 4 How-
ever, the same benign course of UTI may not occur in childhood and in this age
group effective prophylaxis may reduce both morbidity and mortality. 5
Most UTIs arise by ascent of the endogenous bowel flora so that, theoretically at
least, prophylaxis could be achieved by eradicating the source of the pathogens or
by interfering with the ascent of the organisms. The alternative approach to
prophylaxis is to aid the natural defences against UTI.
Table 1. Disability due to genitourinary tract and respiratory infections* (days
per 100 persons per year) .
Female Male Total
Genitourinary infections 45.3 11.2 28.8
Respiratory infections 408.1 327.3 369.1
*Data from HNS survey 1970-71
DHEW Publication 73: 1508
TACKLING THE PROBLEM AT SOURCE
Since there is no evidence that the bowel organisms which cause UTI possess
special pathogenicity for the urinary tract, it follows that nothing short of elimin-
ation of the normal bowel flora would constitute effective prophylaxis. Needless to
say attempts to achieve this on a long-term basis would merely result in bowel
colonization by more resistant strains. A more promising approach might be to
29advise a policy of good perineal hygiene. This might include regular bathing,
correct cleansing after defecation, avoidance of nylon underwear and sanitary
towels and in babies regular nappy changes. None of these measures has been
subjected to the rigours of controlled trials and they are all, therefore, part of
medical folklore which I would not wish to dismiss. The only procedure which has
been studied with care is the application of chlorhexidine ointment to the
perineum, but this was found to be ineffective. 6 Although perineal colonization
precedes invasion of the urinary tract, 7 it appears to be impossible to prevent it
and the defect may well reside in the perineal cells of the host. In this regard it is
of particular interest that Stamey et al 8 and Kallenius and Winberg 9 have shown
that bacteria adhered more readily to vaginal and perineal cells of subjects liable
to recurrent UTI than to those obtained from controls. It has also been suggested
by Svanborg Eden and Svennerholm 10 that secretory IgA antibody directed
against Escherichia coli can prevent the attachment of bacteria to uroepithelial
cells. Local immunization might therefore prove valuable and is certainly worth
investigating. It is also interesting that bacterial adherence to perineal cells can be
inhibited by D-mannose and a-methyl-D-mannoside. Here again new therapeutic
avenues may be opening up to help the unfortunate sufferers from UTI.
Attacks of UTI are frequently precipitated by sexual intercourse. Good sexual
technique together with the advice to empty the bladder after intercourse may
suffice to prevent 'honeymoon cystitis'. Sometimes a single dose of a suitable
antibacterial agent taken after intercourse is also necessary. There is now good
scientific justification for this because intercourse has been shown to produce
bacteriuria in women whose perineum is colonized with E. coli. The practice of
prescribing an antibacterial agent after intercourse is therefore comparable to the
antibiotic cover for dental operations given to patients with rheumatic heart
disease.
Climatic factors may also be important in the pathogenesis of UTI. There have
been several reports to suggest that UTI shows a higher incidence in cold weather.
The most recent study suggests that UTI is particularly likely to occur when the
patient dresses in a manner inappropriate to weather conditions 12 or as Angela
Kilmartin put in her book Understanding cystitis, 13 'If you do decide to go to
Greenland, take some woollen combinations.'
Perhaps the most obvious way of interfering with the ascent of organisms relates
to the infections which follow catheterization and instrumentation. Here good
technique, avoidance of trauma and closed drainage systems are the keys to
success.
In young boys the source of urinary pathogens may be the subprepucial sac
which is often colonized by Proteus spp. Here again good hygiene and in some
cases circumcision, can make a contribution to prophylaxis. In middle aged men
urinary pathogens may lurk in the prostate. It can be particularly difficult to
eliminate organisms from the prostate gland. Only some antibacterial agents (e.g.
trimethoprim, erythromycin and other macrolides and tetracyclines) penetrate the
30prostatic fluid in sufficient concentration and are sufficiently active at the low pH
of prostatic fluid to be useful. In elderly males the problem of UTI is usually
related to prostatic enlargement, and repeated infections which cannot be control-
led by medical means may be an indication for surgical treatment.
AIDING THE NATURAL DEFENCES
As already mentioned, immunization to prevent bacterial colonization of the
perineal floor is a possibility for the future which so far has not materialized. At
present the main methods of aiding natural defences are by a high fluid intake (in
excess of 3 litres/day) and by emptying the bladder frequently and completely.
This aids the hydrokinetic defences and enables polymorphs to function better
since these cells do not phagocytose bacteria as readily in urine of high osmolality
as in urine which approximates to the osmolality of blood. The dilution of anti-
bacterial agents by such a high fluid intake is not important since the urinary
concentrations of most of the commonly used agents far exceeds the minimal
inhibitory concentration (MIC) required to deal with the average urinary
pathogen.
Another possible method of aiding natural defences is to reduce the urinary pH,
for example by a high protein intake. At low pH the organic acids in normal urine
are undissociated and able to penetrate the bacterial cell and so produce their
bactericidal effect. 13 It is difficult, however, to reconcile the production of an acid
urine with a high fluid intake since the hydrogen ion concentration of dilute urine
is reduced accordingly. Because the hydrokinetic defence is of greater importance
than reduction of urinary pH, we do not normally make use of urinary acidifica-
tion as a method of prophylaxis. Yet according to American folklore, eating
cranberries prevents UTI presumably because of their high hippuric acid and
ascorbic acid content.
TREATMENT OF SYMPTOMLESS INFECTIONS
The pioneering work of Kass revealed that for every patient with symptomatic
infection there are at least three apparently healthy people who harbour covert
infection. The question therefore arises to what extent these covert infections lead
to symptomatic infection on the one hand and to progressive kidney damage on
the other. Could these symptomless infections be the submerged part of the iceberg
which accounts for the continuing morbidity associated with UTI ?
The prevalence of these covert infections in different population groups is shown
in Table 2. It must be recognised that these are point prevalences and that covert
bacteriuria is a dynamic state. Figure 1 illustrates the various possible sequelae of
covert infection. The frequency with which the events indicated occur varies from
one population to another, for example, during one year 25% of adult women with
covert infections will be spontaneously cured and 10% of children. However, since
the point prevalence is static, it is clear that the number of women and children
who acquire infection must equal the number who are cured. This is a very impor-
tant observation because if it were true that detection and treatment of covert
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population at frequent intervals in order to make those benefits available to all;
this would be quite impossible. It follows that there is a need to define high risk
groups within the bacteriuric population. Most bacteriuric subjects are 'flitters'
and only in a small percentage (about 10%) does the condition persist. Perhaps
these are the ones who require treatment, or it may be that in these patients the
Population Age range Prevalence
Adult women 21-65 5
Pregnant women 16-40 3
Schoolgirls 5-12 2
Adult males 21-65 0.5
Schoolboys 5-12 0.03
Infants 0-5 0.001
Flo. 1 Dynamics of covert bacteriuria.
After Kunin CM. Detection, prevention and management of urinary tract infection.
3rd ed. Philadelphia: Lea and Febiger, 1979.
32bacteria emanate from the kidney. The advent of a simple non-invasive test of
localization which detects antibody coating on bacteria of renal origin 15 may prove
helpful. There is certainly a need to study the fate of women with renal bacteriuria
separately from that of women in whom the bacteria are confined to the bladder.
In the past, because we did not have a non-invasive method of localization of UTI
we tended to lump all bacteriuric subjects together. It is now clear that bacteriuric
populations are not homogenous and that we need additional markers to identify
subjects who are at high risk of developing symptomatic UTI and/or kidney
damage.
In pregnant women the risk of developing symptomatic UTI is clearly defined.
Thirty per cent of those with covert bacteriuria in early pregnancy which is left
untreated, will suffer from acute pyelonephritis later in the pregnancy. 14 If the
covert infections are treated, however, this can be prevented. Screening for and
treatment of covert infections are worthwhile for three r-easons:
* Spontaneous cures of covert infection in pregnancy are rare, possibly because
the hydrokinetic defences are deranged
* Pregnancy is of short duration and it is easy to eradicate or suppress infection
for 6-7 months
* No special clinic arrangements need to be made since it is only a trivial addition
to routine antenatal care.
There may be other circumstances in which screening and treatment for bac-
teriuria could be worthwhile. For instance, in the elderly the urinary tract is a
common source of Gram-negative septicaemia and this may prove fatal. Here one
could vaccinate against core (Re) antigen of E. coli to prevent endotoxin shock or
one could screen and treat covert infections.
In schoolgirls screening cannot be justified because of the large turnover of
bacteriuria. What is more, both in the adult woman and the schoolgirl with bac-
teriuria, short courses of treatment such as might be used on a large scale tend to
precipitate symptomatic bouts of infection. This is because the reinfections which
follow initially successful treatment are more commonly associated with the
development of symptoms than are the persistent infections in untreated
subjects. 17 It would seem that in some subjects with covert infection the condition
is a kind of symbiosis between host and parasite which is better left undisturbed.
In conclusion, therefore, the only group for which screening for covert infection
has been proved valuable as a prophylactic measure is the pregnant population. It
may be that additional methods will become available to identify high risk groups
within the total bacteriuric population but as yet there is no proven method to
achieve this.
PREVENTION OF RECURRENT INFECTION
After treatment some 50% of infections recur within one year. These recur-
rences are either due to the original infecting strain (relapse) and indicate that
treatment has been ineffective, or they may be due to a different organism
33(reinfection) and indicate defective host defences. Relapsing infections tend to be
more common when the kidneys are involved and they may be prevented by
identifying and dealing with the cause of the relapse. In Table 3 the cause of
relapsing infection and suggested remedies are shown. When no cause or no
Table 3. Causes of relapsing urinary tract infection and suggested remedial action.
Action to be taken
Sometimes it is necessary to start
antibiotic treatment before the
antibiotic sensitivity of the pathogen
is known. In this case it is best to
choose the drug on 'best guess'
principle after consultation with the
local bacteriologist. This may lead to
a wrong choice of drug.
Inadequate duration of treatment.
Emergence of minority resistant
strain.
Inadequate concentration of drug.
Stones
The pathogen should be identified as
soon as possible and treatment started
with the right drug.
A 7-day course of treatment should be
used. If compliance is likely to be poor,
use a long-acting drug.
Retreat with an antibacterial agent to
which the minority strain is sensitive.
Ch'ange to a high dose concentration.
Remove the stones.
treatable cause for relapsing infection is found, long-term prophylaxis is indicated.
This is best achieved by prescribing a nightly dose of an antibacterial agent to
which the organism is sensitive. This is because the longest time between successive
urinary voidings is the night and, therefore, it is then that organisms are most
likely to multiply in the urinary tract. It is important that the drug chosen for
treatment should not produce resistance of the bowel flora otherwise breakthrough
infections are likely. Suitable drugs include nitrofurantoin, since this drug is
absorbed in the small intestine; nalidixic acid, since resistance transfer to this
drug does not occur; or very low doses of cephalexin, since these do not reach
the colon. Trimethoprim and organic acids have also been used very successfully
for long-term prophylaxis of frequently recurring symptomatic relapses.
The problem of symptomatic reinfections is less easy to overcome, although
fortunately they are more widely spaced than the relapses. One way of coping at
least partially with the morbidity they cause is to provide the patient with a dip-
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Cause of relapseslide and a suitable supply of an antibacterial agent to enable her (or him) to start
treatment at the first evidence of the recurrence. At the same time a dip-slide
might be inoculated and sent to the laboratory. In this way morbidity is reduced
to a minimum and bacteriological supervision is retained.
There is still a very long way to go before morbidity from UTI is eliminated but
if a careful assessment of precipitating factors is made by good history taking and
wise use of conservative measures as well as antibacterial agents much can be done
and there will only be a few patients who will need to be told they have to 'live with
the problem'.
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